Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | SLC13A5 | Q86YT5 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | CDC25B | P30305 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27567213 | 0.98 | ALDH1A1 (0.53) | ALDH1A1MAPK1L3MBTL1KMT2ATDP1 | |
| SCHEMBL28002725 | 0.95 | ALDH1A1 (0.59) | ALDH1A1MAPK1L3MBTL1KMT2ATDP1 | |
| Pyrimidine SCHEMBL29089078 | 0.90 | LMNA (0.47) | ALDH1A1MAPK1L3MBTL1KMT2ATDP1 | |
| SCHEMBL29264743 | 0.89 | ALDH1A1 (0.56) | ALDH1A1MAPK1L3MBTL1KMT2ATDP1 | |
| SCHEMBL28803598 | 0.89 | MEN1 (0.49) | ALDH1A1MAPK1L3MBTL1KMT2ALMNA | |
| Phosphoric Acid SCHEMBL27799165 | 0.89 | ALDH1A1 (0.53) | ALDH1A1MAPK1L3MBTL1KMT2ATDP1 | |
| SCHEMBL31033484 | 0.88 | SLC13A5 (0.47) | ALDH1A1MAPK1L3MBTL1KMT2ATDP1 | |
| SCHEMBL32684615 | 0.88 | ALDH1A1 (0.51) | ALDH1A1MAPK1L3MBTL1KMT2ATDP1 | |
| SCHEMBL27620639 | 0.88 | ALDH1A1 (0.51) | ALDH1A1MAPK1L3MBTL1KMT2ATDP1 | |
| SCHEMBL28221087 | 0.88 | ALDH1A1 (0.51) | ALDH1A1MAPK1L3MBTL1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110452508-B | Preparation technology for 3D printing flexible material | 天津科技大学 | 2022-03-08 | — | — | CN | claimed |
| CN-112426389-A | Production process of red cherry lipstick | 邓守毅 | 2021-03-02 | — | — | CN | claimed |
| CN-111289657-A | Method for detecting fruit flavor components in main stream smoke of cigarette | 中国烟草总公司郑州烟草研究院 | 2020-06-16 | — | — | CN | claimed |
| CN-106278881-A | A kind of synthetic method for 3D printing flexible material auxiliary agent | 天津科技大学 | 2017-01-04 | — | — | CN | claimed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-2384193-B1 | VITAMIN D PROMOTING SUNSCREEN | ARMSTRONG ERNEST T (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-113573689-B | Sunscreen composition comprising butyl methoxydibenzoylmethane, triazine derivative and light stabilizer | 巴斯夫欧洲公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-119798352-A | Crystal form of compound YZG-331 and preparation method thereof | 中国医学科学院药物研究所 | 2025-04-11 | — | — | CN | disclosed |
| CN-119700696-A | Tablet for treating insomnia and preparation method thereof | 中国医学科学院药物研究所 | 2025-03-28 | — | — | CN | disclosed |
| CN-116033889-A | Sun protection or daily care composition comprising micronized terphenyl triazine | 巴斯夫欧洲公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-110452508-B | Preparation technology for 3D printing flexible material | 天津科技大学 | 2022-03-08 | — | — | CN | disclosed |
| CN-110452508-B | Preparation technology for 3D printing flexible material | 天津科技大学 | 2022-03-08 | — | — | CN | disclosed |
| EP-2012149-A1 | RETARDATION FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY | Konica Minolta Opto, Inc. (JP) | 2009-01-07 | — | — | EP | disclosed |
| EP-1988877-A2 | THERAPEUTIC COMPOSITIONS COMPRISING INGENOL-3-ANGELATE | Peplin Research Pty Ltd. (AU) | 2008-11-12 | — | — | EP | disclosed |
| US-20080246189-A1 | Cellulose Resin Film, Process for Producing Cellulose Resin Film, Antireflection Film, Polarizing Plate, and Liquid Crystal Display | KONICA MINOLTA OPTO, INC. (JP) | 2008-10-09 | — | — | US | disclosed |
| US-20070247576-A1 | Retardation film, polarizing plate and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2007-10-25 | — | — | US | disclosed |
| WO-2007068963-A2 | THERAPEUTIC COMPOSITIONS COMPRISING INGENOL-3-ANGELATE | PEPLIN RESEARCH PTY LTD (AU) | 2007-06-21 | — | — | WO | disclosed |
| US-20070048459-A1 | Polarizing plate and liquid crystal display apparatus using the same | KONICA MINOLTA OPTO, INC. | 2007-03-01 | — | — | US | disclosed |
| US-20070019133-A1 | Polarizing plate and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-5674874-A | ANTICANCER AGENT | BIONUMERIK PHARMACEUTICALS, INC. (US) | 1997-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | ALDH1A1 697/4885MAPK1 3240/4885L3MBTL1 4774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.